What problem does this paper attempt to address?

This paper aims to explore the inappropriate prophylactic use of peri - operative proton - pump inhibitors (PPIs) and their related factors. Specifically, the main objective of the study is to evaluate the appropriateness of prophylactic use of PPIs in hospitalized patients during the peri - operative period. Secondly, the study also aims to identify the factors associated with inappropriate prophylactic use of PPIs. ### Research Background Stress - related mucosal disease (SRMD) refers to the occurrence of erosions, ulcers and other lesions in the acute gastrointestinal mucosa under stress conditions such as severe trauma, complex surgery or critical illness, which may lead to gastrointestinal bleeding or even perforation. PPIs are commonly used to prevent and treat SRMD because of their strong inhibitory effect on gastric acid secretion. However, in recent years, the problem of irrational use of PPIs in the prevention of SRMD has become increasingly prominent, which not only increases the economic burden on patients and wastes medical resources, but also may bring potential medical risks. ### Research Methods The study adopted a retrospective design and was carried out in Beijing Tongren Hospital (affiliated hospital of Capital Medical University). The study subjects were hospitalized patients who underwent surgery and received prophylactic use of PPIs from June to November 2022. The study collected information such as the patients' age, gender, PPI medication situation, concomitant medications, surgical level, intraoperative blood loss, and postoperative hospital stay through electronic medical records. The rational use of PPIs was independently evaluated by two clinical pharmacists, and the factors associated with inappropriate prophylactic use of PPIs were determined by multivariate logistic regression analysis. ### Main Findings - **Irrational Use Rate**: Among 472 patients, 131 (27.75%) patients had at least one problem of inappropriate prophylactic use of PPIs. - **Main Problems**: - Medication without indication (52.0%) - Inappropriate dosage and frequency of medication (34.6%) - Inappropriate duration of medication (6.7%) - **Related Factors**: - Oral - form PPIs (OR = 18.301, 95% CI (7.497, 44.671), p < 0.001) - Continued use of PPIs at discharge (OR = 11.739, 95% CI (1.289, 106.886), p = 0.029) - Prescriptions written by junior doctors (OR = 9.167, 95% CI (3.459, 24.299), p < 0.001) - Use of anticoagulant drugs (OR = 0.313, 95% CI (0.136, 0.721), p = 0.006) - Postoperative hospital stay exceeding 15 days (OR = 0.262, 95% CI (0.072, 0.951), p = 0.042) ### Conclusion The study found that inappropriate prophylactic use of peri - operative PPIs is relatively common in China, and the main problem is medication without indication. In addition, oral - form PPIs, continued use of PPIs at discharge, and prescriptions written by junior doctors are associated with inappropriate prophylactic use of PPIs. Therefore, regulatory agencies and pharmacists should take more targeted measures to promote the rational prophylactic use of peri - operative PPIs.

Analysis of inappropriate prophylactic use of proton pump inhibitors during the perioperative period: an observational study

Retrospective Comments on Prescriptions of Oral Proton Pump Inhibitors for Outpatients in A General Hospital

Awareness, attitude and behavior regarding proton pump inhibitor among medical staff in the Southwest of China

Effectiveness of Continuous Improvement by a Clinical Pharmacist-Led Guidance Team on the Prophylactic Antibiotics Usage Rationality in Intervention Procedure at a Chinese Tertiary Teaching Hospital

The Inappropriate Prescription of Oral Proton Pump Inhibitors in the Hospital Setting: A Prospective Cross-Sectional Study

Current status and influencing factors of prophylactic use of proton pump inhibitors in internal medicine inpatients receiving glucocorticoid therapy

The Association of Long-Term Use of Proton Pump Inhibitors and Histamine H2 Receptor Antagonists with Clinical Complications in Patients with Severe Sepsis

Individualized prevention of proton pump inhibitor related adverse events by risk stratification

Impact of proton pump inhibitor management committee's multifaceted interventions on acid suppressant prescribing patterns in outpatient and emergency departments

Impact of Interventions Targeting the Inappropriate Use of Proton‐pump Inhibitors by Clinical Pharmacists in a Hepatobiliary Surgery Department

Natural Language Processing Assisted Detection of Inappropriate Proton Pump Inhibitor Use in Adult Hospitalised Patients

Standardized evaluation about single-disease clinical pathway on perioperative use of proton pump inhibitors in a grade 2 and first-class hospital

The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal

Physicians' perceptions and awareness of adverse effects of proton pump inhibitors and impact on prescribing patterns

Rationale use of proton pump inhibitors: Observational study of hospital based prescriptions and role of clinical pharmacist

Primary and Specialty Care Trainees’ Perceptions About Proton Pump Inhibitor Use

Perioperative Utilization of Prophylactic Antimicrobials : Analysis of 956 Cases

Analysis on The Use of Oral Proton Pump Inhibitors in The Inpatients of Peking University Shenzhen Hospital During 2009-2011

Impact of short-term proton pump inhibitors vs. histamine-2 receptor antagonists on gut microbiota in patients with acute coronary syndrome: A multicenter randomized trial

Proton Pump Inhibitors and Oral–Gut Microbiota: From Mechanism to Clinical Significance

Evidence-based evaluation of proton pump inhibitors off-label use